Smith Edward F

Benitec Biopharma Inc. · Director

Smith Edward F is listed in filings as Director at Benitec Biopharma Inc.. This profile follows SEC Form 4 activity through Dec 3, 2025, including 2 public disclosures. Recent filings connect the profile to Benitec Biopharma Inc. (BNTC). The current snapshot covers public activity from Dec 11, 2024 to Dec 3, 2025. Reported amounts are shown as $428.1K to $426.3K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.

Data sources and methodology

History Trades

CompanyValueActionPriceCurrent Price
Historical insider buys and sells before the latest disclosure date will appear here after more snapshots are available.